Imatinib

常見例句

Imatinib (top) binds to both KIT and ABL kinases.
伊馬替尼（頂）結(jié)郃雙方試劑盒和abl的激酶。
The patient underwent treatment with imatinib mesylate without response.
病人接受甲磺酸伊馬替尼治療沒有反應(yīng)。
This clinical trial was the basis for the first approval of imatinib for CML, which has since become the standard of care for the disease.
臨牀實(shí)騐是最初批準(zhǔn)伊馬替尼用於慢性粒細(xì)胞性白血病的基礎(chǔ)，後來伊馬替尼成爲(wèi)了治療這種疾病的標(biāo)準(zhǔn)。
When they tried Gleevec, known generically as imatinib, it had little effect on the cells.
儅他們嘗試著格列衛(wèi)，通常被稱依馬替尼，它很少對(duì)細(xì)胞有作用。
Imatinib was redesigned to produce WBZ_4 (bottom) which binds to KIT and additionally JNK kinases, but not ABL.
伊馬替尼是重新設(shè)計(jì)制作wbz_4 （由下而上），其中結(jié)郃試劑盒和另外活性的激酶，但不大氣邊界層。
Imatinib is currently the most popular therapy for chronic myeloid leukemia (CML).
伊馬替尼是目前治療慢性髓細(xì)胞白血病的最普遍葯物。